jnis.bmj11d
Eligibility for late endovascular treatment using DAWN, DEFUSE-3, and more liberal selection criteria in a stroke center
Background and purpose The real-life application of DAWN and DEFUSE-3 trials has been poorly investigated. We aimed to identify the proportion of patients with acute ischemic stroke (AIS) eligible for ...
jnis.bmj14d
Subarachnoid iodine leakage on dual-energy computed tomography after mechanical thrombectomy is associated with malignant brain edema
Background Dual-energy computed tomography (DE-CT) can differentiate between hemorrhage and iodine contrast medium leakage following mechanical thrombectomy (MT) for acute ischemic stroke (AIS). We ...
jnis.bmj18d
Treatment of intracranial hypertension secondary to superior sagittal sinus stenosis from invasive meningioma
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure without a clear cause, often linked to cerebral venous sinus constriction from embryological or acquired ...
jnis.bmj18d
Prolonged intracranial catheter dwell time exacerbates penumbral stress and worsens stroke thrombectomy outcomes
Background The duration of mechanical thrombectomy (MT) is a negative predictor of outcomes in acute ischemic stroke (AIS), yet the precise mechanisms are unclear. We investigated whether the ...
jnis.bmj20d
Cerebral angiography in outpatient endovascular centers: roadmap and lessons learned from interventional radiology, cardiology, and vascular surgery
In their June 2024 article, Silva and Peterson presented a comprehensive review of the shift from hospitals to ambulatory surgery centers, suggesting that cerebral angiography can feasibly be ...
jnis.bmj26d
Onyx dilution reduces time to resolution of chronic subdural hematomas after middle meningeal artery embolization
Background The benefit of distal embolite penetration for middle meningeal artery (MMA) embolization in chronic subdural hematomas (cSDH) remains controversial. Objective To compare the use of diluted ...
jnis.bmj29d
FRED X flow diversion stenting for unruptured intracranial aneurysms: US multicenter post-market study
Background The Flow Re-direction Endoluminal Device (FRED) X is a next generation flow-diverting stent for treating intracranial aneurysms. Its surface modification (X technology) aims to minimize ...
jnis.bmj29d
Tmax >4 s volume predicts stroke recurrence in symptomatic intracranial atherosclerotic stenosis with optimal medical treatment
Background The time to maximum (Tmax) profile based on computed tomography perfusion (CTP) provides a quantitative assessment of cerebral hemodynamic compromise. We aimed to delineate the Tmax profile ...
jnis.bmj1mon
Neuroanatomy of the vertebrobasilar perforators: implications for aneurysm treatment
The anatomy of vertebrobasilar perforators has been widely studied in human cadavers, with most reports found in the neurosurgical literature. These arterial perforators are extremely hard to ...
jnis.bmj1mon
Comparing validated stroke screening scales for identifying large and medium vessel occlusions: a prospective observational cohort study
Background Rapid prehospital identification of acute ischemic stroke secondary to large vessel occlusions (AIS-LVO) has been successful in triaging patients, but the use of stroke screening scales ...
jnis.bmj1mon
Non-invasive imaging modalities for diagnosing pulsatile tinnitus: a comprehensive review and recommended imaging algorithm
Pulsatile tinnitus (PT) is a challenging diagnostic condition arising from various vascular, neoplastic, and systemic disorders. Non-invasive imaging is essential for identifying underlying causes ...
jnis.bmj1mon
Safety and efficacy of cangrelor in endovascular thrombectomy compared with glycoprotein IIb/IIIa Inhibitors
Background Cangrelor, an intravenous P2Y12-receptor inhibitor, is a reversible and short-acting antithrombotic medication non-inferior to irreversible glycoprotein IIb/IIIa inhibitors (GPIs) like ...